Riskpilot← Back to searchSign inGet full accessGutCRINE ApS
APSActiveCVR 43855565Grønningen 25Research and experimental development on natural sciences and engineering · NACE 7210Est. 20233 employees
Revenue 2025
DKK -2,1M
+61% vs 2024
EBITDA margin
134.2%
-53% vs 2024
Equity ratio
95.5%
Financial strength
Net profit 2025
DKK -2,4M
-99% vs 2024
| Revenue | DKK -2,1M | +61% |
| EBITDA | DKK -2,8M | -53% |
| Net profit | DKK -2,4M | -99% |
| Total assets | DKK 2,4M | -51% |
| Equity | DKK 2,3M | -51% |
| Employees | 3 | — |
Legal name
GutCRINE ApS
CVR number
43855565
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
10. februar 2023
Share capital
DKK 70.368
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af tre bestyrelsesmedlemmer eller af selskabets
direktør og bestyrelsesformanden i forening
Company purpose
Selskabets formål er at drive forskningsvirksomhed rettet mod udvikling af lægemidler til behandling af metabolisme- og neurologiske sygdomme, og/eller at udføre aktiviteter, der er forbundet hermed
Address
Grønningen 25
Phone
+4520580899
Email
tobias@eirventures.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | -2.083 | -1.304 | -2.098 |
| Staff expenses | -292 | -540 | -717 |
| EBITDA | -2.376 | -1.844 | -2.815 |
| Depreciation & amort. | -6 | -11 | -11 |
| EBIT | -2.381 | -1.855 | -2.826 |
| Net financials | -3 | -1 | -1 |
| Profit before tax | -2.385 | -1.856 | -2.827 |
| Tax | -0 | -652 | -434 |
| Net profit | -2.385 | -1.204 | -2.393 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 1.878 | 4.847 | 2.369 |
| Equity | 1.772 | 4.655 | 2.263 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 105 | 192 | 106 |
| Total debt | 105 | 192 | 106 |
EBITDA margin
-281452900.0%
This company
15.8%
Market median
-1781347568% vs market
20232025
Equity ratio
95.5%
This company
38.2%
Market median
+150% vs market
20232025
Return on equity
-105.8%
This company
18.4%
Market median
-675% vs market
20232025
Net profit margin
-239278100.0%
This company
8.1%
Market median
-2954050717% vs market
20232025
Asset turnover
-0.89×
This company
1.12×
Market median
-179% vs market
20232025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20232025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-02-17 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
YF Founder | Founder | 2023 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
YF Holding ApS | Company | 33.3% | 33.3% | 2023 |
Biome Holding ApS | Company | 33.3% | 33.3% | 2023 |
| Individual | 25.0% | 25.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GutCRINE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yong Fan | Founder | 0 companies |
| Tobias Julius Emil Horneman-Thielcke | Chief Executive Officer | 0 companies |
| Stephan Christgau | Chairman | 0 companies |
| Oluf Borbye Pedersen | Board of Directors | 0 companies |